Stockscreener 앱 받기
1.13
3.67%
0.04
전일 마감가:
$1.09
열려 있는:
$1.07
하루 거래량:
220.97K
Relative Volume:
0.44
시가총액:
$110.69M
수익:
$13.56M
순이익/손실:
$-35.57M
주가수익비율:
-2.5405
EPS:
-0.4448
순현금흐름:
$-29.13M
1주 성능:
+0.89%
1개월 성능:
+6.60%
6개월 성능:
-20.98%
1년 성능:
+53.74%
1일 변동 폭
$1.05
$1.13
1주일 범위
$1.03
$1.14
52주 변동 폭
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.13 | 110.69M | 13.56M | -35.57M | -29.13M | -0.4448 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Published on: 2026-04-05 15:20:26 - baoquankhu1.vn
Pullback Watch: Can Hyperfine Inc be recession proofRate Cut & Entry and Exit Point Strategies - baoquankhu1.vn
Hyperfine (HYPR) CFO Brett Hale receives 330,000 RSU equity grant - stocktitan.net
Hyperfine (HYPR) COO receives 330,000 RSUs vesting through multi-year period - stocktitan.net
Hyperfine (HYPR) CEO receives 750,000 RSU stock award - stocktitan.net
Hyperfine (HYPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Hyperfine (HYPR) price target increased by 24.24% to 2.09 - MSN
Inflation Data: Is Hyperfine Inc affected by consumer sentimentMarket Weekly Review & Daily Price Action Insights - baoquankhu1.vn
Aug Action: Is Hyperfine Inc stock showing strong momentumProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn
Hyperfine’s Portable MRI Trial Update Puts Contrast Imaging in the Spotlight - TipRanks
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Benzinga
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Sahm
Brett Hale Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock - MarketBeat
Hyperfine COO Teisseyre sells $29k in shares By Investing.com - Investing.com Australia
Hyperfine COO Teisseyre sells $29k in shares - Investing.com
Hyperfine (HYPR) COO sells shares to cover RSU tax obligations - Stock Titan
Hyperfine (HYPR) CFO Brett Hale sells shares to cover RSU tax obligations - Stock Titan
Hyperfine (HYPR) Q4 2025 Earnings Call Transcript - AOL.com
Hyperfine: $40 Million Loan Facility Secured To Expand Portable MRI Commercialization - Pulse 2.0
Growth Review: Is Hyperfine Inc a play on infrastructure spendingGlobal Markets & Weekly High Return Stock Forecasts - baoquankhu1.vn
Aug Update: How does Hyperfine Inc score in quality rankingsWeekly Trend Summary & Technical Confirmation Alerts - baoquankhu1.vn
Hyperfine Inc stock gains momentum on FDA clearance for Swoop portable MRI system expansion - AD HOC NEWS
Horizon Technology Finance extends USD 40M loan facility to Hyperfine - Medical Buyer
Hyperfine receives $40m from Horizon for Swoop System expansion - Yahoo Finance
Horizon Technology Finance provides $40M loan to Hyperfine By Investing.com - za.investing.com
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine - 01net
Horizon Technology Finance Corporation Provides $40 Million Loan Facility to Hyperfine, Inc - marketscreener.com
Horizon Technology Finance provides $40M loan to Hyperfine - Investing.com
Horizon Technology Finance provides $40 million loan facility to Hyperfine - marketscreener.com
If You Invested $1,000 in HYPERFINE (HYPR) - Stock Titan
Published on: 2026-03-22 05:09:43 - baoquankhu1.vn
Published on: 2026-03-22 02:20:43 - baoquankhu1.vn
Hyperfine, Inc. (NASDAQ:HYPR) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Hyperfine (NASDAQ:HYPR) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Hyperfine Inc. Exposed to Rising Credit Risk as Delayed Customer Payments Threaten Cash Flow and Financial Stability - The Globe and Mail
Hyperfine Inc. Earnings Call Signals Commercial Breakthrough - The Globe and Mail
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript - Insider Monkey
Market Wrap: Is Hyperfine Inc gaining market shareWeekly Trade Summary & Weekly Sector Rotation Insights - baoquankhu1.vn
Lake Street Capital Issues Positive Forecast for Hyperfine (NASDAQ:HYPR) Stock Price - Defense World
Hyperfine (HYPR) Q4 Loss Improvement Tests Bullish Margin Narrative - simplywall.st
Lake Street raises Hyperfine stock price target on revenue growth outlook - Investing.com Australia
Lake Street Raises Price Target for Hyperfine (HYPR) as Buy Rati - GuruFocus
Hyperfine Secures $40 Million Term Loan Financing Agreement - The Globe and Mail
Lake Street Capital Forecasts Strong Price Appreciation for Hyperfine (NASDAQ:HYPR) Stock - MarketBeat
Hyperfine Q4 2025 Financial Results & Swoop System Growth | March 2026News and Statistics - IndexBox
Lake Street raises Hyperfine stock price target on revenue growth outlook By Investing.com - Investing.com South Africa
Hyperfine (HYPR) Q4 2025 Financial Results Conference Call Transcript - Bitget
Guilford medtech firm secures up to $40M in debt financing - Hartford Business Journal
Hyperfine, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
B. Riley Raises Price Target on Hyperfine to $1.60 From $1.30, Keeps Buy Rating - marketscreener.com
Hyperfine reports net loss of USD 5.91M in Q4 2025 - medicalbuyer.co.in
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):